Pharmacovigilance
+7 800-333-43-76
Rus Eng
Main / Portfolio / Endocrinology
  • Own unique technology
  • Full cycle – from a substance to finished dosage form
  • Independence from foreign suppliers of raw stock
  • GEROPHARM insulin substance has been identified* as consistent with the requirements of European and American Pharmacopoeias.
  • Rinsulin substance is ahead of international standards in terms of degree of purification from impurities
  • Modern dosage forms: vials, cartridges, pen-injectors

* Independent certified laboratories: Proteome Factory AG Berlin, Prolytic GmbH Frankfurt am Main, Labor L+S AG
RinLis® (insulin lispro)

More
RinLis® Mix 25 (insulin lispro biphasic 25)

More
RinGlar® (insulin glargine)

More
Rinsapen® II

Individual Pen-injector for insulin injections

More
Rinsapen® I

Creating a reusable pen GEROPHARM pursued the goal to take care of the patients – it was necessary to make a pen-injector maximally convenient for injection of the medicinal product

More
Rinsulin® R

Rinsulin® means reliable control and safety

More
Rinsulin® NPH

Rinsulin® means reliable control and safety

More
Rinsulin® Mix 30/70 (insulin human)

More
Evodin® (evogliptin)

Medicinal product at the stage of development

More
Rinformin® long (metformin long)

More
RinFast® (insulin aspart)

More
RinFast® Mix 30 (insulin aspart binphasic)

More
Insulin Degludec

Medicinal product at the stage of development

More

Pipeline

Areas of development

  • Endocrinology

GEROPHARM is developing a full line of insulin bio analogues that are at different stages of studying.

  • Neurology
  • Orphan diseases
More

See also

Pharmacovigilance

GEROPHARM pays considerable attention to the regulation of drug safety. The company has the pharmacovigilance system which functions in accordance with the requirements of Russian and international regulatory authorities
Scientific Events

GEROPHARM pays considerable attention to the regulation of drug safety. Currently, the company has the pharmacovigilance system which functions in accordance with international requirements and regulatory requirements for the Russian Federation
2018 - CityAD - All rights reserved
Made in

You are a health care professional?

Go up